Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 301

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

Preventive and therapeutic benefits of nelfinavir in rhesus macaques and human beings infected with SARS-CoV-2

Open access
Xu, Zhijian, Shi, Danrong, Han, Jian-Bao, Ling, Yun, Jiang, Xiangrui, Lu, Xiangyun, Li, Chuan, Gong, Likun, Ge, Guangbo, Zhang, Yani, Zang, Yi, Song, Tian-Zhang, Feng, Xiao-Li, Tian, Ren-Rong, Ji, Jia, Zhu, Miaojin, Wu, Nanping, Wu, Chunhui, Wang, Zhen, Xu, Yechun, Peng, Cheng, Zheng, Min, Yang, Junling, Du, Feifei, Wu, Junliang, Wang, Peipei, Shen, Jingshan, Zhang, Jianliang, Zheng, Yong-Tang, Yao, Hangping, Zhu, Weiliang·2023·Signal Transduction and Targeted Therapy

Abstract

Effective drugs with broad spectrum safety profile to all people are highly expected to combat COVID-19 caused by SARS-CoV-2. Here we report that nelfinavir, an FDA approved drug for the treatment of HIV infection, is effective against SARS-CoV-2 and COVID-19. Preincubation of nelfinavir could inhibit the activity of the main protease of the SARS-CoV-2 (IC 50 = 8.26 μM), while its antiviral activity in Vero E6 cells against a clinical isolate of SARS-CoV-2 was determined to be 2.93 μM (EC 50 ). In comparison with vehicle-treated animals, rhesus macaque prophylactically treated with nelfinavir had significantly lower temperature and significantly reduced virus loads in the nasal and anal swabs of the animals. At necropsy, nelfinavir-treated animals had a significant reduction of the viral replication in the lungs by nearly three orders of magnitude. A prospective clinic study with 37 enrolled treatment-naive patients at Shanghai Public Health Clinical Center, which were randomized (1:1) to nelfinavir and control groups, showed that the nelfinavir treatment could shorten the duration of viral shedding by 5.5 days (9.0 vs. 14.5 days, P = 0.055) and the duration of fever time by 3.8 days (2.8 vs. 6.6 days, P = 0.014) in mild/moderate COVID-19 patients. The antiviral efficiency and clinical benefits in rhesus macaque model and in COVID-19 patients, together with its well-established good safety profile in almost all ages and during pregnancy, indicated that nelfinavir is a highly promising medication with the potential of preventative effect for the treatment of COVID-19.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41392-023-01429-0

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 10 references

Cited by

See all 301

Metadata

Authors
Xu, Z., Shi, D., Han, J.-B., Ling, Y., Jiang, X., Lu, X., Li, C., Gong, L., Ge, G., Zhang, Y., Zang, Y., Song, T.-Z., Feng, X.-L., Tian, R.-R., Ji, J., Zhu, M., Wu, N., Wu, C., Wang, Z., Xu, Y., Peng, C., Zheng, M., Yang, J., Du, F., Wu, J., Wang, P., Shen, J., Zhang, J., Zheng, Y.-T., Yao, H., & Zhu, W.
Venue
Signal Transduction and Targeted Therapy
Published
2023-04-24
Volume
8
Issue
1
Pages
169-169
ISSN
2059-3635 (ISSN-L)
OpenAlex
W4366825477
Cited by
301
References
10
FWCI
6.56
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Preventive and therapeutic benefits of nelfinavir in rhesus macaques and human beings infected with SARS-CoV-2. https://app.cochat.ai/papers/10.1038/s41392-023-01429-0
The paper
Xu, Z., Shi, D., Han, J.-B., Ling, Y., Jiang, X., Lu, X., Li, C., Gong, L., Ge, G., Zhang, Y., Zang, Y., Song, T.-Z., Feng, X.-L., Tian, R.-R., Ji, J., Zhu, M., Wu, N., Wu, C., Wang, Z., . . . Zhu, W. (2023). Preventive and therapeutic benefits of nelfinavir in rhesus macaques and human beings infected with SARS-CoV-2. Signal Transduction and Targeted Therapy. https://doi.org/10.1038/s41392-023-01429-0

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.